# Shunt Tube Exposure Prevention Study

> **NCT01551550** · NA · COMPLETED · sponsor: **BioTissue Holdings, Inc** · enrollment: 82 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **PROCEDURE:** GDD
- **PROCEDURE:** Amniotic Membrane Graft
- **PROCEDURE:** Pericardial Graft

## Key facts

- **NCT ID:** NCT01551550
- **Lead sponsor:** BioTissue Holdings, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-12
- **Final completion:** 2019-08-03
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551550, "Shunt Tube Exposure Prevention Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01551550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
